CD24 and neoplasm: There was a significant association between CD44+/CD24 low/− expression and the ability of the tumor to metastasize, as the expression of CD44+/CD24 low/− in patients with distant metastasis was 61% (range: 7–80%), compared to 25.3% (range: 0.1–68%) in those who had not metastasize (P = 0.038).